157 related articles for article (PubMed ID: 11011299)
21. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
[TBL] [Abstract][Full Text] [Related]
22. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
[TBL] [Abstract][Full Text] [Related]
23. Mammographic parenchymal patterns as indicators of breast cancer risk.
Saftlas AF; Wolfe JN; Hoover RN; Brinton LA; Schairer C; Salane M; Szklo M
Am J Epidemiol; 1989 Mar; 129(3):518-26. PubMed ID: 2916545
[TBL] [Abstract][Full Text] [Related]
24. Effect of breast cancer screening after age 65.
Chen HH; Tabar L; Fagerberg G; Duffy SW
J Med Screen; 1995; 2(1):10-4. PubMed ID: 7497137
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program.
Bergkvist L; Tabàr L; Bergström R; Adami HO
Am J Epidemiol; 1987 Dec; 126(6):1075-81. PubMed ID: 3687919
[TBL] [Abstract][Full Text] [Related]
26. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience.
Ciatto S; Zappa M
Eur J Radiol; 1993 Sep; 17(2):122-5. PubMed ID: 8223680
[TBL] [Abstract][Full Text] [Related]
28. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
Tabar L; Fagerberg G; Duffy SW; Day NE
J Epidemiol Community Health; 1989 Jun; 43(2):107-14. PubMed ID: 2512366
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis.
McCann J; Stockton D; Day N
J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460
[TBL] [Abstract][Full Text] [Related]
30. Mammographic screening in older women. Is it worthwhile?
van Dijck JA; Broeders MJ; Verbeek AL
Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
[TBL] [Abstract][Full Text] [Related]
31. New Swedish breast cancer detection results for women aged 40-49.
Tabar L; Duffy SW; Burhenne LW
Cancer; 1993 Aug; 72(4 Suppl):1437-48. PubMed ID: 8339236
[TBL] [Abstract][Full Text] [Related]
32. Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.
Fagerberg G; Baldetorp L; Gröntoft O; Lundström B; Månson JC; Nordenskjöld B
Acta Radiol Oncol; 1985; 24(6):465-73. PubMed ID: 3006435
[TBL] [Abstract][Full Text] [Related]
33. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality.
Larsson LG; Nyström L; Wall S; Rutqvist L; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L
J Med Screen; 1996; 3(3):129-32. PubMed ID: 8946307
[TBL] [Abstract][Full Text] [Related]
34. Mammographic breast cancer screening--a randomized trial in Malmö, Sweden.
Andersson I; Janzon L; Sigfússon BF
Maturitas; 1985 May; 7(1):21-9. PubMed ID: 2991708
[TBL] [Abstract][Full Text] [Related]
35. Interval cancers and cancers in non-attenders in the Ostergötland Mammographic Screening Programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence.
Vitak B; Stål O; Månson JC; Thomas BA; Arnesson LG; Ekelund L; Måre K; Nordenskjöld B; Källström AC; Bång H
Eur J Cancer; 1997 Aug; 33(9):1453-60. PubMed ID: 9337689
[TBL] [Abstract][Full Text] [Related]
36. Early detection of breast cancer.
Threatt B
J Am Med Womens Assoc (1972); 1992; 47(5):152-4. PubMed ID: 1460216
[TBL] [Abstract][Full Text] [Related]
37. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
[TBL] [Abstract][Full Text] [Related]
38. Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer.
Moss SM; Coleman DA; Ellman R; Chamberlain J; Forrest AP; Kirkpatrick AE; Thomas BA; Price JL
Eur J Cancer; 1993; 29A(2):255-8. PubMed ID: 8422291
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis of breast cancer: a clinical and mammographic comparison.
Day PJ; O'Rourke MG
Med J Aust; 1990 Jun; 152(12):635-9. PubMed ID: 2198443
[TBL] [Abstract][Full Text] [Related]
40. Breast screening, prognostic factors and survival--results from the Swedish two county study.
Duffy SW; Tabar L; Fagerberg G; Gad A; Gröntoft O; South MC; Day NE
Br J Cancer; 1991 Dec; 64(6):1133-8. PubMed ID: 1764377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
